GeneNews' Q3 Revenues, Net Loss Rise | GenomeWeb
NEW YORK (GenomeWeb News) – Biomarker test developer GeneNews has reported an increase in its third-quarter 2008 revenue to C$300,000 (US$246,000) from C$200,000 for last year’s third quarter.
The Toronto-based firm said that revenue in the most recent quarter came from a collaboration with an Asian biomedical consortium to identify and validate a set of biomarkers for prostate diseases. That deal was worth US$2 million to GeneNews. The firm’s Q3 2007 revenue came from a collaboration with Pfizer that has since been completed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.